Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01763164 |
|---|---|
| Brief Title: | Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma |
| First Submitted : | January 4, 2013 |
| First Submitted that Met QC Criteria : | January 4, 2013 |
| First Posted : | January 8, 2013 (Estimate) |
| Results First Submitted : | February 11, 2021 |
| Results First Submitted that Met QC Criteria : | March 18, 2021 |
| Results First Posted : | March 22, 2021 |
| Certification/Extension First Submitted : | September 30, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | September 30, 2016 |
| Certification/Extension First Posted : | October 3, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 18, 2021 |
| Last Update Posted : | March 22, 2021 |